Finally, NOTCH1 mutations in NSCLC [99] and ALCL [148], and PIM1 overexpression in neuroblastoma [149], also cause ALK TKI resistance through their effects on the JAK-STAT pathway. This evidence concerns the gene ALK and non-small cell lung carcinoma.